Patent Assignment
Reel/Frame 042821/0362
Change of Name
Recorded: 2017-06-15
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
Compositions Comprising Alternating 2'-Modified Nucleosides for Use in Gene Modulation
Oligomeric Compounds and Compositions for the Use in Modulation of Target Nucleic Acids
5' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
Methods for Modulating Factor 12 Expression
Modulation of Apolipoprotein Ciii (Apociii) Expression
Modulation of Angiopoietin-Like 3 Expression
Conjugated Antisense Compounds and Their Use
Modulation of Hepatitis B Virus (Hbv) Expression
Compositions and Methods for Modulating Hbv Expression
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 2004
From: ALLERSON, CHARLES; BHAT, BALKRISHEN; ELDRUP, ANNE B.; MANOHARAN, MUTHIAH
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 015506/0001 →
Assignment of Assignor's Interest
May 12, 2005
From: ALLERSON, CHARLES; BHAT, BALKRISHEN; ELDRUP, ANNE B.; GRIFFEY, RICHARD H.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016215/0226 →
Confirmatory License
Mar 4, 2013
From: ISIS PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029915/0603 →
Assignment of Assignor's Interest
May 20, 2014
From: PRAKASH, THAZHA P; SETH, PUNIT P.; SWAYZE, ERIC E.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 032934/0511 →
Assignment of Assignor's Interest
Jan 31, 2023
From: IONIS PHARMACEUTICALS, INC.
To: GLAXO GROUP LIMITED
Reel/Frame 062568/0001 →
Corrective Assignment to Correct the Assignment Previously Recorded in Error and Remove All Property Previously Recorded on Reel 062568 Frame 0001. Assignor(S) Hereby Confirms the Assignment.
Dec 22, 2023
From: IONIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC
Reel/Frame 066126/0812 →